Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Vitiligo treatments are improving but relapses are common.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Ocrelizumab may cause total body hair loss in some patients.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Immune therapy for cancer can cause hair loss scars in some patients.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Enhancing Tregs can protect against alopecia areata.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Targeting specific T cells may help treat alopecia areata.

Critically ill patients may experience temporary hair loss after a fever.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

In India, most patients with type 1 autoimmune polyglandular failure show symptoms in a specific order, starting with parathyroid gland issues, then yeast infections, and finally adrenal gland failure.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.